Synergy Pharmaceuticals
$51.8 M
Secondary/Follow-On
Sole Book-Runner
Firsthand Technology Value Fund
$118.8 M
Secondary/Follow-On
Co-Manager
Firsthand Technology Value Fund
$118.8 M
Secondary/Follow-On
Rosetta Genomics Ltd.
$3.1 M
Registered Direct
Sole Book-Runner
TCP Capital Corp.
$84.8 M
IPO
Co-Manager
Garza County Public Facility Corporation
$35.9 M
New Issue
Galectin Therapeutics, Inc.
$12 M
Secondary/Follow-On
Sole Book-Runner
Arlington Asset Investment Corp.
$41.9 M
Secondary/Follow-On
Co-Manager
BGS Acquisition Corp.
$40 M
IPO
Co-Manager
NetSol Technologies, Inc.
$6.7 M
Secondary/Follow-On
Sole Book-Runner
InVivo Therapeutics Holdings, Inc.
$20 M
Secondary/Follow-On
Joint Book-Runner
GSV Capital Corp.
$90 M
Secondary/Follow-On
Co-Manager